On this page
COVID-19 vaccinations summary
Second Boosters Administered | 1,050,411 |
Total Doses Administered | 13,122,228 |
First Boosters Administered | 2,776,064 |
Percentage of 12+ who have completed primary course | 86.6% |
Percentage of eligible 50+ who have received second booster | 57.0% |
Percentage of eligible 18+ who have received first booster | 74.0% |
Metrics on this page can use one of two views of the data - An operational view or a person view.
The operational view shows all doses administered in New Zealand. The person view shows the vaccination status of people regardless of how that was recorded or whether it was in New Zealand. Those who have been vaccinated overseas will only appear in the person view, they will not appear in the operational view.
The person view includes all people that are currently alive and in the latest Health Service User (HSU) population. The current HSU in use is the financial year 2022/23 HSU (FY2022/23 HSU). The HSU is an estimate of the population using the health system in New Zealand. A person is included in the HSU if they use health services (including births and deaths) in the reference period, or are enrolled in a primary health organisation (PHO) during the reference period. The reference period for the FY2022/23 HSU is: 1/7/2022 to 30/6/2023.
Total Vaccinations
Vaccinations last week | Cumulative total | |
---|---|---|
First dose | 3,045 | 4,064,211 |
Second dose | 84 | 3,987,495 |
Booster 1 | 303 | 2,776,064 |
Booster 2 | 2,066 | 1,050,411 |
Booster 3+ | 12,747 | 812,098 |
Paediatric First Dose | 37 | 272,503 |
Paediatric Second Dose | 18 | 159,061 |
Infant First Dose | 0 | 168 |
Infant Second Dose | 0 | 130 |
Infant Third Dose | 0 | 87 |
Total doses | 18,300 | 13,122,228 |
This table is an operational view.
Definitions
- Cumulative total: All vaccinations that have been administered and entered into the Aotearoa Immunisation Register and including Friday 26 April 2024.
- Vaccinations last week: Over the 7 days up to and including Friday 26 April 2024.
Booster breakdowns
Booster counts by ethnicity
Ethnicity | Booster 1 (16-17) | Booster 1 (18+) | Booster 2 (50+) |
---|---|---|---|
Māori | 548 | 253,105 | 65,240 |
Pacific Peoples | 336 | 147,280 | 28,554 |
Asian | 1,073 | 440,715 | 64,694 |
European/Other | 3,320 | 1,796,923 | 691,106 |
Unknown | 11 | 11,449 | 3,267 |
Total | 5,288 | 2,649,472 | 852,861 |
This table is a person view.
Booster 2 uptake by age group
Age Group | Eligible | Received | Uptake |
---|---|---|---|
18 to 34 | 162,059 | 39,689 | 24.5% |
35 to 49 | 618,689 | 125,024 | 20.2% |
50 to 64 | 721,346 | 292,004 | 40.5% |
65+ | 773,684 | 560,857 | 72.5% |
This table is a person view.
Vaccine uptake percentage by age band
Vaccine uptake percentage by District of residence 12+
Vaccinations by week
This chart shows the count of vaccinations administered in a given week from the Aotearoa Immunisation Register. Note some records are entered in the register at a later date than the immunisation was received. This means that the figures for a given date may move for some time after that date.
Adverse events following immunisations (AEFI)
Like all medicines, the COVID-19 vaccine may cause side effects in some people. These are common, are usually mild, don’t last long and won’t stop people from having the second dose or going about daily life. Serious allergic reactions do occur but are extremely rare.
Suspected AEFI to COVID-19 vaccines are reported to the Centre for Adverse Reactions Monitoring (CARM). Medsafe is closely monitoring the AEFI reported from the use of the COVID-19 vaccine and will report regularly on their findings.
View Medsafe data on COVID-19 vaccine adverse effects following immunisation